Vaccine considerations for adult dermatology patients on immunosuppressive and immunomodulatory therapies: a clinical review [PDF]
, 2021 Adults with chronic inflammatory skin disease are at increased risk of vaccine-preventable illnesses and infections, likely because of the underlying disease itself and also their treatment with immunosuppressive and immunomodulatory medications. Despite
Noe, Megan H +7 more
core +1 more source
Defining patient-centered research priorities in pediatric dermatology [PDF]
, 2022 Background/objectives: Patient and caregiver perspectives are critical in understanding dermatologic disease impact, presentation, and management in children.
Rittle, James +17 more
core +1 more source
Evaluation of malondialdehyde in vitiligo patients as a marker of lipid peroxidation [PDF]
Zagazig University Medical Journal, 2023 :Background : Vitiligo is a chronic depigmented skin disorder with melanocytes depletion. The pathogenesis of melanocyte damage in vitiligo is still unclear. However, there were some in vivo and in vitro studies that indicate the role of oxidative stress
noha elsayed +3 more
doaj +1 more source
Celebrating 20 years of the UK Dermatology Clinical Trials Network. Part 1: Developing and delivering high-quality independent clinical trials [PDF]
, 2022 The UK Dermatology Clinical Trials Network (UK DCTN) was formed in 2002 with the aim of developing and supporting high-quality independent national clinical trials that address prioritized research questions for people with skin disease.
UK Dermatology Clinical Trials Network +8 more
core +1 more source
Pakistan Armed Forces Medical Journal, 2022 Objective: To compare the efficacy of topical Betamethasone valerate 0.1% w/v and topical Ketoconazole 2% w/v in patients of seborrheic dermatitis. Study Design: Comparative prospective study. Place and Duration of Study: Department of Dermatology,
Muhammad Rizwan +3 more
doaj +1 more source
Celebrating 20 years of the UK Dermatology Clinical Trials Network. Part 2: education, training and capacity building [PDF]
, 2022 In Part 1 of this 2-part review of the 20th anniversary of the UK Dermatology Clinical Trials Network (UK DCTN), we described its role in developing and supporting clinical trial proposals, elaborating on structure, process and clinical trials activity ...
Layfield, Carron P. +2 more
core +1 more source
Avoidable research waste in dermatology: what are the solutions? [PDF]
, 2022 In the last editorial, I provided examples of research waste in dermatology and suggested that it was due to a system failure rather than just a few “bad apples”.
Williams, Hywel C, Williams, H. C.
core +1 more source
The American Journal of the Medical Sciences, 1886 n ...
LOUIS A. DUHRING, HENRY W. STELWAGON
openaire +2 more sources
Recommended core outcome instruments for health‐related quality of life, long‐term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting [PDF]
, 2020 Background: The Harmonising Outcome Measures for Eczema (HOME) initiative has established a core outcome set of domains for atopic eczema (AE) clinical trials. Previous consensus meetings have agreed on preferred instruments for clinician-reported signs (
Gerbens, L. A. A. +49 more
core +1 more source
Indian Dermatology Online Journal, 2022 In dermatology, “pseudo” is often used as a prefix for entities resembling another standard condition, either morphologically or histopathologically. Correspondingly, “pseudotumor” is a term encompassing dermatological conditions which are not true proliferations, but either have a clinical resemblance to a known tumor (e.g ...
Vishal Gaurav, Chander Grover
openaire +3 more sources